Table 6.
I 2 statistic value of each variable at different follow up in each meta‐analysis
| Outcomes | Handoll et al. (2013)12 | Li et al. (2013)16 | Mao et al. (2014)17 | Jia et al. (2014)14 | Fu et al. (2014)13 | Sun et al. (2015)15 | Mao et al. (2015)18 | Rabi et al. (2015)19 | Li et al. (2016)20 | Du et al. (2017)21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Constant score | 0% | 0% | 0% | 0% | 42% | 0% | ‐ | |||
| Constant score at 4 months | 60% | |||||||||
| Constant score at 6 months | — | |||||||||
| Constant score at 12 months | 0% | 0% | — | 0% | 24% | |||||
| Constant score at 24 months | 0% | 0% | — | |||||||
| Constant score at 50 months | — | — | ||||||||
| DASH | 0% | |||||||||
| DASH at 4 months | 0% | |||||||||
| DASH at 12 months | 0% | 0% | — | |||||||
| DASH at 24 months | 0% | 0% | — | |||||||
| ASES score | — | |||||||||
| ASES at 6 months | — | — | ||||||||
| ASES at 12 months | — | — | ||||||||
| SST at 3 months | — | |||||||||
| SST at 12 months | — | |||||||||
| VAS score | 0% | |||||||||
| Functional outcome | 0% | 0% | ||||||||
| Poor or unsatisfactory function | — | |||||||||
| ROM | — | — | ||||||||
| Quality of life | — | 3.1% | 0% | |||||||
| EQ‐5D | 0% | 0% | ||||||||
| EQ‐5D at 4/6 months | 48%/10% | 0%/− | ||||||||
| EQ‐5D at 12/24 months | 0%/0% | 0%/0% | 0%/0% | |||||||
| 15D | 0% | |||||||||
| 15D at 3/6/12 months | 0%/0%/0% | — | — | |||||||
| Activities of daily living | — | |||||||||
| Total complications | 85% | 23% | 8% | |||||||
| Additional surgery | 0% | 0% | 0% | 0% | ||||||
| Additional surgery at 12 months | 0% | 0% | ||||||||
| Additional surgery at 24 months | 0% | 0% | ||||||||
| Fixation failure resulting in an operation | — | |||||||||
| Axillary nerve lessions | 0% | — | ||||||||
| AVN | 0% | 0% | 41.9% | — | 0% | 0% | ||||
| Bone resorption | — | 60% | — | |||||||
| Hematoma | — | |||||||||
| Implant penetration | 0% | 0% | — | |||||||
| Impingement and stiffness | — | — | ||||||||
| Infection | 4 | 0% | — | 0% | ||||||
| Mortality | 0% | 0% | 0% | |||||||
| Nonunion | 0% | 0% | 0% | — | 0% | 0% | ||||
| Number of QALY at 1 year | 0% | |||||||||
| Osteoarthritis | 42% | 13% | 52% | — | 0% | 36% | 27% | |||
| Pain and impairment | — | — | ||||||||
| Pulmonary embolism | — | |||||||||
| Redisplacement of fracture | 0% | 0% | — | |||||||
| Refracture | — |
15D, 15 Dimensions; ASES, American Shoulder and Elbow Surgeons; AVN, Avascular Necrosis; DASH, disabilities of the arm, shoulder and hand; ROM; Range of Motion; SST, Simple Shoulder Test; VAS, Visual Analogue Scale.